Factor V inhibitor in neonatal intracranial hemorrhage secondary to severe congenital factor V deficiency

We report a newborn infant girl, born to consanguine ous parents, with recurrent intracranial hemorrhage secondary to congenital factor V deficiency with factor V inhibitor. Repeated transfusions of fresh-frozen plasma (FFP) and platelet concentrates, administrations of immunosuppressive therapy (pr...

Full description

Saved in:
Bibliographic Details
Main Authors: Lee, Way Seah, Chong, L.A., Begum, S., Abdullah, W.A., Koh, M.T., Lim, E.J.
Format: Article
Published: Lippincott, Williams & Wilkins 2001
Subjects:
Online Access:http://eprints.um.edu.my/10924/
http://journals.lww.com/jpho-online/Abstract/2001/05000/Factor_V_Inhibitor_in_Neonatal_Intracranial.13.aspx
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:We report a newborn infant girl, born to consanguine ous parents, with recurrent intracranial hemorrhage secondary to congenital factor V deficiency with factor V inhibitor. Repeated transfusions of fresh-frozen plasma (FFP) and platelet concentrates, administrations of immunosuppressive therapy (prednisolone and cyclophosphamide), and intravenous immunoglobulin failed to normalize the coagulation profiles. Exchange transfusion followed-up by administrations of activated prothrombin complex and transfusions of FFP and platelet concentrates caused a temporary normalization of coagulation profile, enabling an insertion of ventriculoperitoneal (VP) shunt for progressive hydrocephalus. The treatment was complicated by thrombosis of left brachial artery and ischemia of left middle finger. The child finally died from another episode of intracranial hemorrhage 10 days after insertion of the VP shunt.